News and Trends 25 Oct 2022
Delayed release tablets to treat ulcerative colitis launched in Canada
With Canada having one of the highest incidences of ulcerative colitis in the world, the recent launch of Tillotts Pharma AG’s Octasa 800 mg will be well-received. Tillotts is part…